Multiple myeloma highlights at ASH 2017
The future is bright for hematological oncology: promising areas for 2018 and beyond
iwNHL 2017: The future of lymphoma research and treatment
Catherine Bollard et al.
BTK inhibition in primary CNS lymphoma
Developments in multiple myeloma - immunotherapy and personalized medicine